Martine van Vugt

Direktor/Vorstandsmitglied bei SCANDION ONCOLOGY A/S

71 Jahre

Health Technology

Consumer Services

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Jan van de Winkel	M	63	GENMAB A/S	25 Jahre
Johnny Stilou	M	57	SCANDION ONCOLOGY A/S	3 Jahre
Deirdre Connelly	F	63	GENMAB A/S	7 Jahre
Martin Møller	M	49	SCANDION ONCOLOGY A/S	3 Jahre
Jørgen Vilhelm Bardenfleth	M	69	SCANDION ONCOLOGY A/S	6 Jahre
Pernille Erenbjerg	F	57	GENMAB A/S	9 Jahre
Tahamtan Ahmadi	M	51	GENMAB A/S	7 Jahre
Jan Stenvang	M	-	SCANDION ONCOLOGY A/S	7 Jahre
Anthony Pagano	M	46	GENMAB A/S	17 Jahre
Susan Coles	F	58	TME PHARMA N.V.	3 Jahre
Paolo Augusto Paoletti	M	73	GENMAB A/S	9 Jahre
Marisol Peron	F	-	GENMAB A/S	5 Jahre
Keld Flintholm Jørgensen	M	53	SCANDION ONCOLOGY A/S	2 Jahre
Elizabeth O'Farrell	F	59	GENMAB A/S	2 Jahre
Alejandra Maria Mørk	M	63	SCANDION ONCOLOGY A/S	2 Jahre
Rolf K. Hoffmann	M	64	GENMAB A/S	8 Jahre
Maarten Ligtenberg	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Peter Michael Vestlev	M	-	SCANDION ONCOLOGY A/S	-
Martin Schultz	M	49	GENMAB A/S	2 Jahre
Takahiro Hamatani	M	50	GENMAB A/S	2 Jahre
Nicky Vogels	F	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Christopher Cozic	M	46	GENMAB A/S	-
Anthony Mancini	M	53	GENMAB A/S	4 Jahre
Allard Kaptein	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Mijke Zachariasse	M	51	GENMAB A/S	5 Jahre
Morten Nissen	M	-	SCANDION ONCOLOGY A/S	-
Judith Klimovsky	M	67	GENMAB A/S	7 Jahre
Shobhit Dhawan	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Birgitte Stephensen	F	63	GENMAB A/S	22 Jahre
Andrew Carlsen	M	-	GENMAB A/S	5 Jahre
François Martelet	M	64	SCANDION ONCOLOGY A/S	1 Jahre
Anders Gersel Pedersen	M	73	GENMAB A/S	21 Jahre
Lars Damstrup	M	-	SCANDION ONCOLOGY A/S	1 Jahre

Mehr sehen

Beziehungs-Chart

Beziehungen zu mehreren Unternehmen

Ehemalige Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Daniel John Bruno	M	45	GENMAB A/S	5 Jahre
Bo Rode Hansen	M	-	SCANDION ONCOLOGY A/S	2 Jahre
Michael Blair Widmer	M	76	GENMAB A/S	11 Jahre
Mats Gunnar Pettersson	M	78	GENMAB A/S	7 Jahre
Bo Kruse	M	52	GENMAB A/S	8 Jahre
Christina Hahner	F	-	GENMAB A/S	-
Jonathan Peacock	M	66	GENMAB A/S	1 Jahre
Tom Vink	M	61	GENMAB A/S	-
Nedjad Losic	M	54	GENMAB A/S	-
Michael K. Bauer	M	60	GENMAB A/S	14 Jahre
Helle Husted	F	-	GENMAB A/S	-
Rachel Curtis Gravesen	F	55	GENMAB A/S	8 Jahre
Nils Aage Brünner	M	72	SCANDION ONCOLOGY A/S	-
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 Jahre
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 Jahre
Bertram Köhler	M	53	TME PHARMA N.V.	5 Jahre
Lisa N. Drakeman	M	70	GENMAB A/S	11 Jahre
Burt Malkiel	M	90	GENMAB A/S	11 Jahre
Antonius Theodorus M Wilderbeek	M	74	GENMAB A/S	2 Jahre
Maj Hedtjärn	M	-	SCANDION ONCOLOGY A/S	1 Jahre
Joseph deBethizy	M	74	TME PHARMA N.V.	7 Jahre
Eva Ehrnrooth	M	57	GENMAB A/S	2 Jahre
Suba Krishnan	M	59	GENMAB A/S	1 Jahre
Richard Gordon Hibbert	M	44	GENMAB A/S	3 Jahre
Peter Storm Kristensen	M	49	GENMAB A/S	-
Rima Bawarsh Nassar	M	70	GENMAB A/S	-
Steen Lisby	M	60	GENMAB A/S	9 Jahre
Joris Wilms	M	50	GENMAB A/S	2 Jahre
Christian Vinding Thomsen	M	-	SCANDION ONCOLOGY A/S	5 Jahre
Nicklas Lindland Roest	F	39	SCANDION ONCOLOGY A/S	-
Jorgen Petersen	M	-	GENMAB A/S	-
Patrick van Berkel	M	55	GENMAB A/S	9 Jahre
Irwin Lerner	M	93	GENMAB A/S	-
Alfredo Zurlo	M	-	SCANDION ONCOLOGY A/S	-
Rikke Glahn Ren	F	-	GENMAB A/S	-
Barry Littlejohns	M	58	GENMAB A/S	-
Hanne Damgaard Jensen	F	-	GENMAB A/S	8 Jahre
Paul W. H. I. Parren	M	60	GENMAB A/S	16 Jahre
Annarie Lyles	M	63	GENMAB A/S	-
David Andrew Eatwell	M	63	GENMAB A/S	12 Jahre
Joseph Fred Yospe	M	66	GENMAB A/S	2 Jahre
Michael Wolff Jensen	M	53	GENMAB A/S	3 Jahre
Claus Juan Møller-San Pedro	M	62	GENMAB A/S	9 Jahre
Ernst H. Schweizer	M	-	GENMAB A/S	-
Bryan Jennings	M	-	TME PHARMA N.V.	1 Jahre
Gregory Weaver	M	68	TME PHARMA N.V.	1 Jahre
Mads Aaboe Jensen	M	-	SCANDION ONCOLOGY A/S	-

Statistik

Land	Beziehungen	% des Gesamten
Dänemark	71	88,75%
Deutschland	5	6,25%
Niederlande	4	5,00%

Alter der Beziehungen

Aktive

Vergangene

Herr

Frau

Aufsichtsräte

Führungskräfte

Ursprung der Beziehungen

Börse
Insiders
Martine van Vugt
Persönliches Netzwerk